PUS7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.264400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.106800E-01
Normal-vs-Stage2
4.367600E-01
Normal-vs-Stage3
8.573800E-01
Normal-vs-Stage4
1.594370E-01
Stage1-vs-Stage2
9.217400E-01
Stage1-vs-Stage3
2.853400E-01
Stage1-vs-Stage4
3.726800E-01
Stage2-vs-Stage3
2.641600E-01
Stage2-vs-Stage4
5.163200E-01
Stage3-vs-Stage4
1.160620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.169600E-01
Normal-vs-AfricanAmerican
3.258400E-01
Normal-vs-Asian
7.904000E-01
Caucasian-vs-AfricanAmerican
5.795400E-01
Caucasian-vs-Asian
2.701600E-01
AfricanAmerican-vs-Asian
2.042800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.435000E-01
Normal-vs-Female
4.103400E-01
Male-vs-Female
8.501600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.460600E-01
Normal-vs-Age(41-60Yrs)
1.978840E-01
Normal-vs-Age(61-80Yrs)
5.388200E-01
Normal-vs-Age(81-100Yrs)
4.010200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.018590E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.851400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.867600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.349020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.184400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.317800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.524800E-01
Normal-vs-Daily Drinker
6.698800E-01
Normal-vs-Weekly Drinker
4.354800E-01
Normal-vs-Occasional Drinker
1.174390E-01
Normal-vs-Social Drinker
2.684400E-01
Non Drinker-vs-Daily Drinker
6.151200E-01
Non Drinker-vs-Weekly Drinker
6.610600E-01
Non Drinker-vs-Occasional Drinker
7.384600E-01
Non Drinker-vs-Social Drinker
1.618190E-01
Daily Drinker-vs-Weekly Drinker
3.826800E-01
Daily Drinker-vs-Occasional Drinker
3.236400E-01
Daily Drinker-vs-Social Drinker
7.596000E-02
Weekly Drinker-vs-Occasional Drinker
7.973600E-01
Weekly Drinker-vs-Social Drinker
4.213600E-01
Occasional Drinker-vs-Social Drinker
2.199200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.599000E-01
Normal-vs-Grade 2
8.300200E-02
Normal-vs-Grade 3
1.283240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.543800E-02
Grade 1-vs-Grade 3
2.927900E-02
Grade 1-vs-Grade 4
2.599000E-01
Grade 2-vs-Grade 3
2.101400E-01
Grade 2-vs-Grade 4
8.300200E-02
Grade 3-vs-Grade 4
1.283240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.096800E-01
Normal-vs-NonDiabetic
3.932400E-01
Diabetic-vs-NonDiabetic
5.148600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.789800E-01
Normal-vs-NoPancreatitis
4.532200E-01
Pancreatitis-vs-NoPancreatitis
9.248200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.560800E-01
Normal-vs-N1
4.213800E-01
N0-vs-N1
9.301800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.716600E-01
Normal-vs-TP53-NonMutant
4.765200E-01
TP53-Mutant-vs-TP53-NonMutant
4.435600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
